United Therapeutics (UTHR) Non Operating Income (2009 - 2026)

United Therapeutics has disclosed Non Operating Income across 18 years of filings, most recently posting $41.9 million for Q2 2026.

• In Q2 2026, Non Operating Income fell 4.56% year-over-year to $41.9 million; the TTM figure through Jun 2026 stood at $171.2 million (up 1.36% YoY), while the FY2025 annual figure was $221.4 million, up 36.67% from the prior year.
• Non Operating Income came in at $41.9 million for Q2 2026 at United Therapeutics, up from -$7.5 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $87.3 million in Q4 2025 to a low of -$51.2 million in Q2 2022.
• Average Non Operating Income over 5 years is $26.6 million, with a median of $35.4 million recorded in 2023.
• Year-over-year, Non Operating Income plunged 798.25% in 2022 and surged 1477.78% in 2023.
• Over 5 years, Non Operating Income stood at $3.2 million in 2022, then soared by 1003.12% to $35.3 million in 2023, then rose by 9.92% to $38.8 million in 2024, then jumped by 125.0% to $87.3 million in 2025, then sank by 52.0% to $41.9 million in 2026.
• Per Business Quant data, the three most recent Non Operating Income figures were $41.9 million in Q2 2026, -$7.5 million in Q1 2026, and $87.3 million in Q4 2025.